Fig. 1 · Structure

Documents & Downloads

Procyanidin B3

Cat. No. A12688 CAS 23567-23-9
Procyanidin B3 is a B type proanthocyanidin. Procyanidin B3 is a catechin dimer. It can be found in barley, in beer, in peach or in Jatropha macrantha, the Huanarpo Macho. It has been identified as an hair-growth stimulant

In Stock

Publications for Procyanidin B3

7 publications citing this product

  1. Darshika Pathiraja, .et al. , Food Chem, 2023, May 1;407:135145 PMID: 36521391
  2. Keji Yu, .et al. , Nat Commun, 2022, Jun 14;13(1):3425 PMID: 35701431
  3. Ji Hyung Jun, .et al. , Sci Adv, 2021, May 14;7(20) PMID: 33990337
  4. Elessawy FM, .et al. , Phytochem Anal, 2019, Dec 23 PMID: 31869515
  5. Jun JH, .et al. , Nat Plants, 2018, Dec;4(12):1034-1043 PMID: 30478357
  6. Angela Wang, .et al. , Int J Mol Sci, 2016, Dec; 17(12): 2065 PMID: 27941690
  7. Chenggang Liu, .et al. , Nat Plants, 2016, Nov 21;2:16182 PMID: 27869786

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
MT4 CC50 117.8 μg/mL Cytotoxicity against human MT4 cells by MTT assay [PMID: 10425115]
MT4 IC50 27 μg/mL Antiviral activity against HIV infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay [PMID: 10425115]

Procyanidin B3 Research Summary

This section summarizes 1 in vitro study and 1 in vivo study of Procyanidin B3 from 1 published reference. In vitro models include primary epiphyseal chondrocytes isolated from 5-day-old mice.

Procyanidin B3 In Vitro Studies

In primary mouse chondrocytes, procyanidin B3 (5 or 50 µg/ml) reduced LDH-defined injury following hydrogen peroxide exposure over 24 h. This endpoint measures cellular injury and does not specifically establish apoptosis. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

B3 reduces oxidative injury in primary mouse chondrocytes

Cell-based study · Primary epiphyseal chondrocytes isolated from 5-day-old mice [1]

B3 reduced hydrogen-peroxide-associated LDH release and preserved adherent cell morphology. LDH is a membrane-injury readout and does not specifically identify apoptosis.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Cellular injury after hydrogen peroxide exposureLDH cytotoxicity Reduced with 5 and 50 µg/ml B3; p<0.05 for indicated comparisons; mean and SD; n=5 samples/group.[1]

Literature-Reported Treatment Conditions

Treatment concentration
B3 5 and 50 µg/ml; H2O2 500 µM
Exposure duration
24 h injury endpoint
Method
B3 pre-incubation followed by H2O2 according to Results; methods describe H2O2 with or without B3.
Reported limits
Pre-incubation interval and vehicle composition are not specified in the inspected methods/results. No exact numerical LDH percentage transcribed from bars.
Methods and source locations

Compound reported in the paper: Procyanidin B3; Compound label in the paper: B3

Preclinical observations with isolated B3; no clinical efficacy or direct target assignment.

Reagents; Cell Culture Conditions; Measurement of Cellular Injury; Figure 1 and caption; relevant Results

Cellular injury after hydrogen peroxide exposure: LDH release assay, supported by phase-contrast microscopy. — Figure 1a–e and caption; Measurement of Cellular Injury; Results, Effects of B3 on H2O2-induced Chondrocyte Apoptosis

Procyanidin B3 In Vivo Studies

In a surgical mouse osteoarthritis model, oral procyanidin B3 reduced cartilage damage and TUNEL-positive chondrocytes at four weeks. Treatment began five days after surgery and was given five days per week. These preclinical findings do not establish clinical efficacy. [1]

Oral B3 in a surgical mouse osteoarthritis model

Animal study · Male C57BL/6J mice, approximately 3 months old; surgically induced left-knee OA, contralateral right-knee sham surgery; n=10/group [1]

B3 reduced histological cartilage damage and superficial-cartilage TUNEL labeling at four weeks after surgery. These observations do not establish human benefit or a direct molecular target.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Histological articular-cartilage damageMankin histologic score Approximately 50% of control values (reported in Results); p<0.05; mean ± SD, 10 samples/group.[1]
TUNEL-positive chondrocytes in superficial articular cartilageTUNEL-positive cell count Almost one-third of control (reported in Results); p<0.05, Mann–Whitney U test; mean ± SD, 10 mice/group.[1]

Conditions shared by the study groups

Route
Oral
Frequency
Once per dosing day, five days/week (Results and Figure 3 caption); methods use once-a-day wording.
Treatment course
From day 5 after surgery until the four-week tissue endpoint
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
B3 versus vehicle after OA surgery
1 mg/10 g body weight
Vehicle-treated OA group; right knees underwent sham surgery.Lower Mankin score and fewer superficial-cartilage TUNEL-positive cells; reduced pseudocapsule thickness and ectopic cartilage frequency shown in Figure 3.[1]
B3 versus vehicle after OA surgery
Model: Male C57BL/6J surgical OA mice; n=10 in each treatment group
Reported limits: Vehicle composition, dosing device, randomization and blinding are not specified in inspected methods.
Methods and source locations

Compound reported in the paper: Procyanidin B3; Compound label in the paper: B3

Preclinical observations with isolated B3; no clinical efficacy or direct target assignment.

Reagents; Animals; Surgical Induction of OA; Assessment of OA Severity; TUNEL Assay; Figures 3–4 and captions; corresponding Results

Histological articular-cartilage damage: Safranin O–fast green histology and Mankin scoring. — Figure 3A–B and caption; Assessment of OA Severity; Results, Prevention of Cartilage Destruction and Ectopic Cartilage Formation

TUNEL-positive chondrocytes in superficial articular cartilage: TUNEL staining of knee-joint sections. — Figure 4A–B and caption; TUNEL Assay; Results, Prevention of Cartilage Destruction and Ectopic Cartilage Formation

B3 versus vehicle after OA surgery · Surgical Induction of OA; Figures 3–4 and captions; Results, Prevention of Cartilage Destruction and Ectopic Cartilage Formation

Specifications

Manufacturer Adooq Bioscience
CAS Number 23567-23-9
Formula C30H26O12
Molecular Weight 578.52
Synonyms Proanthocyanidin B3; Procyanidol B3
SMILES
C1[C@@H]([C@H](OC2=C1C(=CC(=C2[C@H]3[C@@H]([C@H](OC4=CC(=CC(=C34)O)O)C5=CC(=C(C=C5)O)O)O)O)O)C6=CC(=C(C=C6)O)O)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Procyanidin B3 Research References

  1. [1] Aini H, Ochi H, Iwata M, et al. Procyanidin B3 prevents articular cartilage degeneration and heterotopic cartilage formation in a mouse surgical osteoarthritis model. PloS one (2012). PMID: 22629448 DOI: 10.1371/journal.pone.0037728 Source material

Publications

7 publications citing this product

  1. Darshika Pathiraja, .et al. , Food Chem, 2023, May 1;407:135145 PMID: 36521391
  2. Keji Yu, .et al. , Nat Commun, 2022, Jun 14;13(1):3425 PMID: 35701431
  3. Ji Hyung Jun, .et al. , Sci Adv, 2021, May 14;7(20) PMID: 33990337
  4. Elessawy FM, .et al. , Phytochem Anal, 2019, Dec 23 PMID: 31869515
  5. Jun JH, .et al. , Nat Plants, 2018, Dec;4(12):1034-1043 PMID: 30478357
  6. Angela Wang, .et al. , Int J Mol Sci, 2016, Dec; 17(12): 2065 PMID: 27941690
  7. Chenggang Liu, .et al. , Nat Plants, 2016, Nov 21;2:16182 PMID: 27869786

Added to your cart

View Cart Checkout
Loading...